Description
MGCD-265 Analog is an inhibitor of MET that may exhibit anticancer potential.
Product Unit Size | Cost | Quantity | Stock |
---|
MGCD-265 Analog is an inhibitor of MET that may exhibit anticancer potential.
Cas No. | 875337-44-3 |
---|---|
Purity | ≥98% |
Formula | C26H20FN5O2S2 |
Formula Wt. | 517.60 |
Chemical Name | N-[[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-phenylacetamide |
IUPAC Name | N-[[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-phenylacetamide |
Synonym | MGCD-265; MGCD265; MGCD 265 Analog, MGCD265 Analog, MGCD-265 Analog, Glesatinib Analog |
Solubility | DMSO 104 mg/mL (200.92 mM) Water Insoluble Ethanol Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Belalcazar A1, Azaña D, Perez CA, et al. Targeting the Met pathway in lung cancer. Expert Rev Anticancer Ther. 2012 Apr;12(4):519-28. PMID: 22500688.
Type A trichothecene mycotoxin produced by Fusa...
β2-adrenergic agonist.
Camptothecin derivative; topoisomerase I inhibi...
Peptidyl transferase inhibitor, protein transla...
V2 antagonist.
Thienylbutyl ITC analog.
BH3 mimetic; Bcl-2 and Bcl-xl inhibitor.
Triterpene saponin found in Panax; Kv7.1 K+ cha...
Tetrapeptide, binds cell surface integrins.
Peptide; serine protease inhibitor.
Dual kinase and GTPase inhibitor.
Core structure of melatonin; potential PPARγ a...
Induces DNA strand breakage.
c-MET inhibitor.
Pim-1 inhibitor.
Purine derivative; CDK inhibitor.
TGFbeta receptor inhibitor
4-Hydroxytamoxifen prodrug; FIASMA, SERM, PKC i...
Endogenous tachykinin peptide, involved in infl...
Diphenylmethane, inhibits secretion of cortisol...